beta-lapachone has been researched along with Cancer of Skin in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bang, W | 1 |
| Jeon, YJ | 1 |
| Cho, JH | 1 |
| Lee, RH | 1 |
| Park, SM | 1 |
| Shin, JC | 1 |
| Choi, NJ | 1 |
| Choi, YH | 1 |
| Cho, JJ | 1 |
| Seo, JM | 1 |
| Lee, SY | 1 |
| Shim, JH | 1 |
| Chae, JI | 1 |
1 other study available for beta-lapachone and Cancer of Skin
| Article | Year |
|---|---|
β-lapachone suppresses the proliferation of human malignant melanoma cells by targeting specificity protein 1.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Dow | 2016 |